C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
260/305, 260/315
C07D 233/56 (2006.01) C07D 403/12 (2006.01) C07D 521/00 (2006.01)
Patent
CA 1108137
ABSTRACT N-(Phenoxyalkyl)imidazole of the formula: Image wherein R is NO2, CN, SO2NH2, C1-C4 alkanoyl, CO2R , CH2CO2R , OCH2CO2R , CONHR3, CH2CONHR3, OCH2CONHR3, CON(R4)2, CH2CON(R4)2, OCH2CON(R4)2, NHR5, CH2NHR5, tetrazolyl, CH2-tetrazolyl and OCH2-tetrazolyl; R1 is H, C1-C4 alkyl, C1-C4 alkoxy or halogen; R2 is H or C1-C4 alkyl; R3 is H, C1-C4 alkyl, C1-C4 alkanoyl, C1-C4 alkylsulphonyl, CN, benzoyl or benzenesulphonyl, the phenyl ring in said benzoyl or benzenesulphonyl groups being optionally substituted with one or more C1-C4 alkyl, C1-C4 alkoxy or CF3 groups or halogen atoms; each R4 is C1-C4 alkyl or two groups R4 together with the nitrogen atom to which they are attachet form a pyrrolidino, piperidino or morpholino group; R5 is H, C1-C4 alkanoyl, C1-C4 alkoxycarbonyl, carbamoyl, C1-C4 alkylcarbamoyl; and n is 2 or 3; and the pharmaceutically acceptable acid addition salts there- of and bioprecursors therefor, are able to selectively inhibit the action of the thromboxane synthetase enzyme without significantly inhibiting the action of the prostacycline synthetase or cyclooxygenase enzymes and are thus useful in the trestment of ischaemic heart disease, stroke, transient ischaemic attack, thrombosis, migraine and the vascular complications of diabetes.
341691
Cross Peter E.
Dickinson Roger P.
Pfizer Corporation
Smart & Biggar
LandOfFree
N-(phenoxyalkyl)imidazoles as selective inhibitors of the... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with N-(phenoxyalkyl)imidazoles as selective inhibitors of the..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and N-(phenoxyalkyl)imidazoles as selective inhibitors of the... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-992309